Review article · 2026
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
Nature Reviews Drug Discovery, 25(4), 268–289 · Published 5 January 2026 · DOI 10.1038/s41573-025-01336-9
In brief
“Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications” is a 2026 review article by T. Haikarainen and 3 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 21 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 21
- Most cited in
- 2026 (21)
- Field-weighted impact
- 11.14
- References
- 273
- Authors
- 4
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Haikarainen, T., Virtanen, A. T., Cravatt, B. F., & Silvennoinen, O. (2026). Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications. Nature Reviews Drug Discovery, 25(4), 268–289. https://doi.org/10.1038/s41573-025-01336-9
MLA 9
Haikarainen, T., et al. “Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications.” Nature Reviews Drug Discovery, vol. 25, no. 4, 2026, pp. 268–289. https://doi.org/10.1038/s41573-025-01336-9.
Chicago
Haikarainen, T., Anniina T. Virtanen, Benjamin F. Cravatt, and Olli Silvennoinen. 2026. “Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications.” Nature Reviews Drug Discovery 25 (4): 268–289. https://doi.org/10.1038/s41573-025-01336-9.
Harvard
Haikarainen, T. et al. (2026) ‘Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications’, Nature Reviews Drug Discovery, 25(4), pp. 268–289. doi:10.1038/s41573-025-01336-9.
IEEE
T. Haikarainen, A. T. Virtanen, B. F. Cravatt, and O. Silvennoinen, “Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications,” Nature Reviews Drug Discovery, vol. 25, no. 4, pp. 268–289, 2026, doi: 10.1038/s41573-025-01336-9.
BibTeX
@article{haikarainen2026pharmacological,
title = {{Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications}},
author = {Haikarainen, T. and Virtanen, Anniina T. and Cravatt, Benjamin F. and Silvennoinen, Olli},
journal = {Nature Reviews Drug Discovery},
year = {2026},
volume = {25},
number = {4},
pages = {268--289},
doi = {10.1038/s41573-025-01336-9},
url = {https://doi.org/10.1038/s41573-025-01336-9}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- JAK/STAT signaling
- JAK inhibitors
- STAT inhibitors
- cytokine receptors
- signal transduction
- drug development
- autoimmune disease
- haematological diseases
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Haikarainen, T., Virtanen, A. T., Cravatt, B. F., & Silvennoinen, O. (2026). Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications. Nature Reviews Drug Discovery, 25(4), 268–289. https://doi.org/10.1038/s41573-025-01336-9
How many times has this paper been cited?
21 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
T. Haikarainen, Anniina T. Virtanen, Benjamin F. Cravatt, Olli Silvennoinen.
What is the DOI of this paper?
10.1038/s41573-025-01336-9, permanently at https://doi.org/10.1038/s41573-025-01336-9. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.